FY2023 Separation Roadmap
FY2023 Separation Roadmap
FY2023
CMS/C&I
FY2023
Actual
Separation
Adjusted
☐
Separation of CMS/C&I for FY23 would
result in 150 bps margin uplift
Adj. Net Revenue*
$13,301
($5,438)
$7,863
☐
■ Impact before any further benefit from
Cost Optimization Plan
Adj. EBITDA*
Margin %
1,436
(465)
971
10.8%
8.6%
12.3%
(+150 bps)
CMS/C&I Financials
☐
Revenues of $5,438M composed of CMS segment revenue of $4,694M plus net revenue from the portion of DVS included
in the separation of $744M ($807M gross revenue)
Adjusted EBITDA margin of 7.7% (as disclosed in transaction presentation) included:
Estimated $10M in incremental standalone costs
Estimated ~$30M in unallocated Jacobs corporate costs that support
CMS/C&I business
*See Non-GAAP reconciliation and operating metrics at the end of presentation
15 Figures are based on preliminary unaudited information and may not be reflective of Carve-Out Financial Statements prepared in accordance with US GAAP.
Jacobs 2024View entire presentation